| 000 | 01076 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514213950.0 | ||
| 264 | 0 | _c20060801 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a1592-8721 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZeis, Matthias | |
| 245 | 0 | 0 |
_aVaccination against lymphoma. _h[electronic resource] |
| 260 |
_bHaematologica _cJan 2005 |
||
| 300 |
_a3 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xblood |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Anti-Idiotypic _ximmunology |
| 650 | 0 | 4 | _aAntibody Formation |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 |
_aHSP70 Heat-Shock Proteins _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xphysiology |
| 650 | 0 | 4 |
_aLymphoma _xprevention & control |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xprevention & control |
| 650 | 0 | 4 | _aMycobacterium tuberculosis |
| 650 | 0 | 4 | _aVaccination |
| 650 | 0 | 4 |
_aVaccines, DNA _xtherapeutic use |
| 773 | 0 |
_tHaematologica _gvol. 90 _gno. 1 _gp. 3 |
|
| 999 |
_c15323863 _d15323863 |
||